>US Stocks>Optimi Health

$2.27$-3.81 (-62.66%)in 1 year

As on 13 Nov 2026 at 02:28NASDAQ

52 Week Low: $1.9052 Week High: $6.40

Optimi Health Share Price Today

Optimi Health opened lower at $2.34, compared with its previous close of $2.40. In the last trading session, the stock traded between $2.05 and $2.48. It showed a downward intraday trend.

Return calculator

You have invested

Time Period

An investment of $100 made 1 year ago in Optimi Health is now worth

$ 37.34

Resulting in a loss of

$ 62.66 (62.66%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

No analyst rating data available.

Markets Today

Today's Change

$-0.13 (-5.42%)

Day High

$2.48

Day Low

$2.05

Day Open

$2.34

Prev Close

$2.40

Volume

53,169

1W Return

1.16%

1M Return

-35.49%

3M Return

-52.06%

6M Return

-62.66%

1Y Return

-62.66%

Fundamentals

Market Cap ($ Mn)

PE Ratio

PB Ratio

2.27

PEG Ratio

ROE

-45.07%

ROCE

-32.29%

EPS (TTM)

$-0.42

Investment Returns

1 Week

1.16%

1 Month

-35.49%

3 Months

-52.06%

6 Months

-62.66%

9 Months

-62.66%

Financials

Quarterly

All values in $ Mn

0.1

Mar 25

0.2

Jun 25

0.0

Sep 25

0.0

Dec 25

0.1

Mar 26

0.1

Jun 26

Updates

20Oct

Optimi Health completes MDMA batch for proposed 2027 Phase 3 trial

Completed production of MDMA capsules at Princeton, British Columbia GMP facility. Supply allocated to Canadian Phase 3 trial (2027), Australian exports (2026), and Israel trial. Proposed Canadian trial targets up to 100 veterans and frontline workers with PTSD. Over 750 Australian clinicians certified; no reported serious adverse events since 2024.

23 days ago

Similar Stocks

Stock	LTP	Change %	Market Cap	PE
L Eli Lilly	$1,437.29	+0.35%	$13,52,123.38M	39.43
J Johnson & Johnson	$280.41	-0.13%	$6,75,033.80M	31.06
A Abbvie	$294.98	+0.37%	$5,21,411.37M	72.17
M Merck & Co	$147.18	-0.59%	$3,62,834.91M	117.74
N Novartis AG	$160.32	-1.80%	$3,26,222.34M	23.23
A Astrazeneca	$185.48	-0.69%	$2,87,691.54M	24.32
A AMGEN	$468.11	+0.62%	$2,53,205.85M	26.86
G Gilead Sciences	$169.73	-0.67%	$2,10,522.74M	-
P Pfizer	$29.45	+0.31%	$1,67,860.70M	36.79
N Novo Nordisk	$41.09	+0.96%	$1,39,300.36M	11.15
B Bristol Myers Squibb	$62.91	+0.18%	$1,28,593.45M	14.67
S Sanofi	$48.43	+0.41%	$1,16,984.89M	23.63